LPS and TNF-α treatment reduced XB130 protein level in cultured human bronchial epithelial cells (unpublished data); LPS may inhibit XB130 expression and reduce the protective effects of XB130 in ALI. This evidence concerns the gene AFAP1L2 and acute respiratory distress syndrome.